Previous 10 | Next 10 |
A look at the top 10 most actives in the United States Trio Petroleum Corp. (TPET) rose 43.8% to $0.1485 on volume of 202,621,744 shares Nikola Corporation (NKLA) fell 5.5% to $0.9736 on volume of 187,304,976 shares C3is Inc. (CISS) rose 13.3% to $0.0409 on volume of 136,767,990 shares ...
A look at the top 10 most actives in the United States Trio Petroleum Corp. (TPET) rose 63.6% to $0.168949 on volume of 119,634,330 shares C3is Inc. (CISS) rose 17.5% to $0.0424 on volume of 56,452,737 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 6.6% to $3.315 on volume...
2024-04-01 15:08:10 ET NRX Pharmaceuticals, Inc. (NRXP) Q4 2023 Earnings Conference Call April 1, 2024 08:30 ET Company Participants Matthew Duffy - Chief Business Officer Jonathan Javitt - Founder & Chief Scientist Stephen Willard - Chief Executive Officer ...
2024-04-01 09:02:02 ET NRx Pharmaceuticals Inc (NRXP) announced stock split at a ratio of 1-for-10 on 2024-04-02 ... Full story available on KlickAnalytics.com
2024-04-01 08:57:08 ET More on NRx Pharmaceuticals NRx Pharma to distribute HOPE Therapeutics stock, pay Ketamine royalty to holders NRx unveils plan to battle naked short selling in shares Seeking Alpha’s Quant Rating on NRx Pharmaceuticals Historical...
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update PR Newswire Four potential near-term milestones, including data from two clinical trials, an NDA filing and an upcoming share dividend -- 50% redu...
2024-03-28 14:53:54 ET More on NRx Pharmaceuticals NRx Pharma to distribute HOPE Therapeutics stock, pay Ketamine royalty to holders NRx unveils plan to battle naked short selling in shares Seeking Alpha’s Quant Rating on NRx Pharmaceuticals Historical...
2024-03-28 08:40:17 ET More on NRx Pharmaceuticals NRx Pharma to distribute HOPE Therapeutics stock, pay Ketamine royalty to holders NRx unveils plan to battle naked short selling in shares Seeking Alpha’s Quant Rating on NRx Pharmaceuticals Historical...
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights PR Newswire Four potential near-term milestones, including data from two clinical trials, an NDA filing and a share dividend RAD...
NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing PR Newswire Common Stock Will Begin Trading on Split-Adjusted Basis on April 2, 2024 RADNOR, Pa. , March 28, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx ...
News, Short Squeeze, Breakout and More Instantly...
NRX Pharmaceuticals Inc. Company Name:
NRXP Stock Symbol:
NASDAQ Market:
NRX Pharmaceuticals Inc. Website:
NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing PR Newswire New Drug Application (NDA) for Accelerated Approval planned for NRX-101 in people with bipolar depression and akathisia in 202...
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024 PR Newswire RADNOR, Pa. , June 20, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals"...
NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors PR Newswire Dr. Dennis McBride brings extensive experience in Neuroscience and its interface with Information and Medical Technology ...